T

Telomir Pharmaceuticals Inc
NASDAQ:TELO

Watchlist Manager
Telomir Pharmaceuticals Inc
NASDAQ:TELO
Watchlist
Price: 1.42 USD 1.43% Market Closed
Market Cap: 48.8m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of TELO.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TELO Intrinsic Value
Not Available
T
Base Case Scenario
Compare TELO to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TELO?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Telomir Pharmaceuticals Inc

Current Assets 7.4m
Cash & Short-Term Investments 7.3m
Other Current Assets 72.8k
Current Liabilities 422.8k
Accounts Payable 329.4k
Other Current Liabilities 93.4k
Efficiency

Free Cash Flow Analysis
Telomir Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Telomir Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-11.3m USD
Operating Income
-11.3m USD
Other Expenses
59.2k USD
Net Income
-11.3m USD
Fundamental Scores

TELO Profitability Score
Profitability Due Diligence

Telomir Pharmaceuticals Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Exceptional ROIC
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
36/100
Profitability
Score

Telomir Pharmaceuticals Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

TELO Solvency Score
Solvency Due Diligence

Telomir Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Telomir Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TELO Price Targets Summary
Telomir Pharmaceuticals Inc

There are no price targets for TELO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Telomir Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TELO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TELO Insider Trading
Buy and sell transactions by insiders